Erika Bartel
La Plata, B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study.
Journal: Lancet regional health. Americas
Published: December 12, 2022
Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.
Journal: Emerging infectious diseases
Published: October 19, 2019
A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against Bordetella pertussis, Including Pertactin Deficient Strains.
Journal: Frontiers in cellular and infection microbiology
Published: December 08, 2018
Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against Bordetella parapertussis Infection.
Journal: Frontiers in immunology
Published: May 03, 2018
Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
Journal: Applied and environmental microbiology
Published: August 25, 2017
Pertussis Maternal Immunization: Narrowing the Knowledge Gaps on the Duration of Transferred Protective Immunity and on Vaccination Frequency.
Journal: Frontiers in immunology
Published: June 01, 2017
Characterization of the immune response induced by pertussis OMVs-based vaccine.
Journal: Vaccine
Published: November 26, 2015
Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.
Journal: Vaccine
Published: August 21, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026